Company: XTIA
Filing Date: 2025-09-12
Form Type: 424B5
Source: 0001213900-25-087270
Chunk: 28

Company: XTI Aerospace, Inc.
Filing Date: 2025-09-12
Form: 424B5
Chunk 28
---
 following      
 issuances subsequent to June 30, 2025 through September 10, 2025: (i) the issuance of 1,371,000 shares of common stock, at               
 the public offering price of $1.75 per share, for net proceeds of approximately $2.2 million, in connection with the closing of multiple 
 exercises of the over-allotment option granted to the underwriter of the June Offering during July 2025, (ii) the issuance of 115,000    
 shares of common stock pursuant to the exercise of 115,000 common warrants for aggregate net proceeds of approximately $0.2 million,     
 which warrants were issued in connection with an underwritten public offering of our securities that closed on March 31, 2025, (iii)     
 the issuance of 785,276 shares of common stock pursuant to the cashless exercise of 785,700 pre-funded warrants, which warrants were     
 issued in the June Offering, and (iv) the issuance of 66,700 shares of common stock pursuant to the exercise of 66,700 common warrants   
 for aggregate net proceeds of approximately $0.1 million, which warrants were issued in the June Offering (collectively, the “pro        
 forma adjustments”); and                                                                                                                 |
| ● | on a pro forma as adjusted basis to give further effect to the issuance                                                                  
 and sale of (i) 10,575,000 shares of common stock and Common Warrants to purchase 10,575,000 shares of our common stock in this offering 
 at a public offering price of $1.60 per share and accompanying Common Warrant, and (ii) Pre-funded Warrants to purchase up to 1,925,000  
 shares of our common stock and Common Warrants to purchase 1,925,000 shares of our common stock in this offering at a public offering    
 price of $1.599 per Pre-funded Warrant and accompanying Common Warrant, assuming the full exercise of the Pre-funded Warrants for cash,  
 resulting in the issuance of 12,500,000 shares of common stock, and after deducting placement agent fees and estimated offering expenses 
 payable by us.                                                                                                                           |

You should read this table together with the section of this prospectus supplement titled “Use of Proceeds,” as well as our consolidated financial statements and the related notes and the sections titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for